Hantz Financial Services’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2K Buy
+58
New +$1.52K ﹤0.01% 2321

Other funds holding ARQT

Hantz Financial Services's ARQT Position: Q3 2026 in Review

Hantz Financial Services opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 58 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2321 among its holdings.

294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Hantz Financial Services held 58 shares of Arcutis Biotherapeutics worth $2K as of Q3 2026.
  • Arcutis Biotherapeutics was a new Hantz Financial Services position in Q3 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Hantz Financial Services's portfolio in Q3 2026, its #2321 holding.
  • 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Hantz Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.